Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Medicine

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjmed.2013.02.001PMID 23490060PMCID PMC3926199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.

  2014cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Effect of oral digoxin in high‐risk heart failure patients: a pre‐specified subgroup analysis of the DIG trial

  2013cited by this paper
• Centers for Medicare & Medicaid Services (CMS)

  2013cited by this paper
• Heart failure in the lifetime of Musca domestica (the common housefly).

  2013cited by this paper
• Hospital strategies to reduce heart failure readmissions: where is the evidence?

  2012cited by this paper
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• Effect of nesiritide in patients with acute decompensated heart failure.

  2011cited by this paper
• Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.

  2009cited by this paper
• Rehospitalizations among patients in the Medicare fee-for-service program.

  2009cited by this paper
• Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.

  2009cited by this paper
• Mortality and Readmission for Patients With Heart Failure Among U.S. News & World Report’s Top Heart Hospitals

  2009cited by this paper
• Reconsidering the role for digoxin in the management of acute heart failure syndromes.

  2009cited by this paper
• Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

  2007cited by this paper
• Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure.

  2007cited by this paper
• Association between performance measures and clinical outcomes for patients hospitalized with heart failure.

  2007cited by this paper
• Contemporary Use of Digoxin in the Management of Cardiovascular Disorders

  2006cited by this paper
• Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial

  2006cited by this paper
• Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

  2006cited by this paper
• Nationwide Frequency and Costs of Potentially Preventable Hospitalizations, 2006: Statistical Brief #72

  2006cited by this paper
• Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

  2005cited by this paper
• Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.

  2005cited by this paper
• Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

  2004cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

  2003cited by this paper
• Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

  2003cited by this paper
• Determination of vital status at the end of the DIG trial.

  2003cited by this paper
• In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction.

  2001cited by this paper
• Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

  2001cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• The effect of digoxin on mortality and morbidity in patients with heart failure.

  1997cited by this paper
• Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

  1996cited by this paper
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

  1995cited by this paper
• Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy.

  1995cited by this paper
• Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

  1995cited by this paper
• Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

  1993cited by this paper
• Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

  1993cited by this paper
• Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.

  1993cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy.

  1983cited by this paper

• Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record

  2024cites this paper
• Assessment and Management of Atrial Fibrillation in Older Adults with Frailty

  2024cites this paper
• Targeting Troponin C with Small Molecules Containing Diphenyl Moieties: Calcium Sensitivity Effects on Striated Muscles and Structure-Activity Relationship

  2023cites this paper
• Targeting Troponin C with Small Molecules Containing Diphenyl Moieties: Calcium Sensitivity Effects on Striated Muscle and Structure Activity Relationship

  2023cites this paper
• Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction

  2022cites this paper
• Design and Rationale of the National Tunisian Registry of Heart Failure (NATURE-HF): Protocol for a Multicenter Registry Study

  2021cites this paper
• Drugs Used in Heart Failure

  2021cites this paper
• Pharmacologic Support of the Failing Heart

  2020cites this paper
• Does digoxin relieve outcomes in patients with chronic heart failure with reduced ejection fraction?

  2020cites this paper
• Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.

  2020cites this paper
• Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.

  2020cites this paper
• Are corticosteroid injections a useful adjunctive treatment with physical therapy for lateral epicondylitis?

  2020cites this paper
• Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.

  2020cites this paper
• Digitoxin Attenuates Heart Failure, Reduces Myocardial Hypertrophy, and Preserves the Calcium-Binding Proteins in Infarcted Rats

  2019cites this paper
• Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

  2019cites this paper
• Interrupção da digoxina e desfechos em pacientes com insuficiência cardíaca com fração de ejeção reduzida

  2019influential citation
• Digoxin Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction.

  2019cites this paper
• Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study.

  2019cites this paper
• Digoxin use and lower risk of 30‐day all‐cause readmission in older patients with heart failure and reduced ejection fraction receiving β‐blockers

  2018cites this paper
• Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study

  2018cites this paper
• Discharge home health services referral and 30-day all-cause readmission in older adults with heart failure

  2018cites this paper
• Clinical Use of Digitalis: A State of the Art Review

  2018cites this paper
• Drug treatment of heart failure in the elderly

  2018cites this paper
• Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.

  2018cites this paper
• Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.

  2017cites this paper
• The synthesis of cardenolide and bufadienolide aglycones, and related steroids bearing a heterocyclic subunit.

  2017cites this paper
• Palliative Care for Advanced Heart Failure in a Department of Veterans Affairs Regional Hospice Program: Patient Selection, a Treatment Protocol, and Clinical Course

  2017cites this paper
• Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.

  2017cites this paper
• Chronic Heart Failure Clinical Practice Guidelines’ Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

  2016cites this paper
• Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction

  2016cites this paper
• Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death.

  2016cites this paper
• Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

  2016cites this paper
• Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?

  2016cites this paper
• Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.

  2016cites this paper
• Contemporary Controversies in Digoxin Use in Systolic Heart Failure

  2016cites this paper
• Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".

  2016cites this paper
• Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization

  2016cites this paper
• Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales

  2016cites this paper
• Inappropriate use of digoxin in patients presenting with digoxin toxicity

  2015cites this paper
• Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data

  2015cites this paper
• Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure

  2015cites this paper
• Update for 2014 on clinical cardiology, geriatric cardiology, and heart failure and transplantation.

  2015cites this paper
• Use of digoxin in chronic systolic heart failure in current era.

  2015cites this paper
• The reply.

  2015cites this paper
• The End of the Digoxin Era

  2015cites this paper
• Digoxin-associated mortality: a systematic review and meta-analysis of the literature.

  2015cites this paper
• Actualización 2014 en cardiología clínica, cardiología geriátrica e insuficiencia cardiaca y trasplante

  2015cites this paper
• Kontrola częstości rytmu serca w wybranych chorobach serca Heart rate control in selected cardiac diseases

  2015cites this paper
• Evaluating multiple endpoints in heart failure clinical trials

  2015cites this paper
• Team-Based Care for Outpatients with Heart Failure.

  2015cites this paper
• Digoxin use may increase the relative risk of acute pancreatitis.

  2015cites this paper
• Atrial fibrillation Digoxin-associated mortality : a systematic review and meta-analysis of the literature

  2015cites this paper
• Digitalis for treatment of heart failure in patients in sinus rhythm.

  2014cites this paper
• The endless story of digitalis.

  2014cites this paper
• Drugs Used in Heart Failure

  2014cites this paper
• Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.

  2014cites this paper
• Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.

  2014cites this paper
• Inhibiting Na+/K+ ATPase Can Impair Mitochondrial Energetics and Induce Abnormal Ca2+ Cycling and Automaticity in Guinea Pig Cardiomyocytes

  2014cites this paper
• Emergency Department Visits and Hospitalizations for Digoxin Toxicity: United States, 2005 to 2010

  2014cites this paper
• A perspective on re‐evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile

  2014cites this paper
• The reply.

  2014cites this paper
• The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions.

  2014cites this paper
• Drug therapy to reduce early readmission risk in heart failure: ready for prime time?

  2013cites this paper
• Return of digoxin and recovery of renal function.

  2013cites this paper
• Summary of the Clinical Studies Reported in the Annual Scientific Sessions of the American College of Cardiology (San Francisco, CA, United States, March 8-12, 2013)

  2013cites this paper
• Progress or lack of progress in hospitalized heart failure

  2013cites this paper
• Report of the American College of Cardiology (ACC) Scientific Sessions 2013, San Francisco--highlighting late-breaking trials.

  2013cites this paper
• Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (San Francisco, California, Estados Unidos, 8-12 de marzo de 2013)

  2013cites this paper
• Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

  2004cites this paper